Active ingredientIbipinabantCat. No. P-I003-001CAS 362519-49-1Family · Pharmaceutical analytical standards
Ibipinabant
A selective cannabinoid CB1 receptor antagonist, designed in 2000 and studied as a possible anti-obesity drug for its appetite-reducing effect; it never reached the market and has remained a laboratory research tool. This family brings together the active ingredient.
Did you know?The -nabant ending of its name is the stem that international drug nomenclature reserves for cannabinoid receptor blockers, such as rimonabant and taranabant.
Go to the active ingredient →Active ingredientIbipinabantCat. No. P-I003-001CAS 362519-49-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.